Q1 2019 Holdings
Filed 2019-05-15 | 64 holdings | $138.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $70.6M | 600,000 | 51.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $34.3M | 275,000 | 24.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $26.8M | 850,000 | 19.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $3.0M | 200,000 | 2.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.5M | 420,555 | 1.8% |
| Inflarx NV(IFRX) | COM | N44821101 | $97.9K | 2,590,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $83.8K | 925,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $78.8K | 1,075,000 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $70.2K | 3,600,000 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $67.2K | 920,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $56.6K | 1,100,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $52.6K | 615,000 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $48.0K | 1,411,898 | 0.0% |
| Quotient LTD | SHS | G73268107 | $41.4K | 4,600,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $39.0K | 1,009,586 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $36.0K | 450,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $35.8K | 300,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $35.1K | 2,525,900 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $35.0K | 300,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $32.1K | 900,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $31.2K | 600,000 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $30.5K | 1,272,495 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $30.4K | 750,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $29.8K | 1,700,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $24.8K | 450,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $23.2K | 1,400,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $23.1K | 1,300,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $21.9K | 550,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $20.7K | 130,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $18.8K | 715,482 | 0.0% |
| Constellation Pharmaceuticals I(CNST) | COM | 210373106 | $17.2K | 1,271,687 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $16.8K | 500,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $16.4K | 706,064 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $15.5K | 650,000 | 0.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $14.2K | 250,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $14.2K | 653,129 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $14.0K | 780,018 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $12.5K | 600,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $12.2K | 500,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $11.9K | 507,564 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $11.8K | 650,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $11.6K | 650,143 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $11.2K | 250,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $10.3K | 350,000 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $9.0K | 400,000 | 0.0% |
| Genfit S A | ADS | 372279109 | $8.4K | 350,000 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $8.0K | 839,642 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.9K | 90,000 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $6.6K | 300,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $6.4K | 673,891 | 0.0% |